Fierce Pharma Asia—Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament
Fierce Pharma Asia—Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament aliu Thu, 03/28/2024 - 16:45
Fierce Pharma Asia—Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament aliu Thu, 03/28/2024 - 16:45
Genmab expands US headquarters, plots 300 hires amid launch of AbbVie-partnered lymphoma med Epkinly fkansteiner Thu, 03/28/2024 - 16:02
Amneal pulls 4 lots of antibiotic vancomycin due to potentially overfilled, extra-potent bottles zbecker Thu, 03/28/2024 - 14:37
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies jpiatt Thu, 03/28/2024 - 13:03
Johnson & Johnson gets a new opportunity to contest science in talc litigation kdunleavy Thu, 03/28/2024 - 12:23
Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides jpiatt Thu, 03/28/2024 - 11:25
Intelligence officials warned lawmakers WuXi AppTec furnished China with client's intellectual property: Reuters fkansteiner Thu, 03/28/2024 - 10:24
Abzena earmarks $5M to bolster ADC, complex biologic services at Pennsylvania site jkeenan Thu, 03/28/2024 - 07:54
Akebia's Vafseo finally gets its shot at US chronic kidney disease market after FDA approval zbecker Wed, 03/27/2024 - 17:00